Organisms | Evidence |
---|---|
Human immunodeficiency virus 1 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
P12259 | Coagulation factor V | ||
P12272 | Parathyroid hormone-related protein | ||
P12643 | Bone morphogenetic protein 2 | ||
P12645 | Bone morphogenetic protein 3 | ||
P12830 | Cadherin-1 | ||
P13224 | Platelet glycoprotein Ib beta chain | ||
P13473 | Lysosome-associated membrane glycoprotein 2 | ||
P13591 | Neural cell adhesion molecule 1 | ||
P13611 | Versican core protein | ||
P13645 | Keratin, type I cytoskeletal 10 |
Pathway Name | Organism |
---|---|
E.coli O101 | Escherichia coli |
E.coli O103 | Escherichia coli |
E.coli O107 | Escherichia coli |
E.coli O112ab | Escherichia coli |
E.coli O112ac | Escherichia coli |
E.coli O116 | Escherichia coli |
E.coli O117 | Escherichia coli |
E.coli O125ab | Escherichia coli |
E.coli O127 | Escherichia coli |
E.coli O128ab-H27 | Escherichia coli |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
15465091 | Neurophysiological and immunohistochemical studies on Guillain-Barré syndrome with IgG anti-GalNAc-GD1a antibodies—effects on neuromuscular transmission | Taguchi K | 2004 Oct 15 |
|
15509179 | Design and Synthesis of Novel N-Acetylgalactosamine-Terminated Glycolipids for Targeting of Lipoproteins to the Hepatic Asialoglycoprotein Receptor | Rensen PC | 2004 Oct 06 |
|
15573367 | Specific detection of O‐linked N‐acetylhexosamine modified peptides using multiple precursor ion scans | Rogalski JC | 2004 Nov 30 |
|
15620693 | A novel β1,3‐N‐acetylglucosaminyltransferase (β3Gn‐T8), which synthesizes poly‐N‐acetyllactosamine, is dramatically upregulated in colon cancer | Ishida H | 2004 Nov 28 |
|
15571382 | Site-Specific Incorporation of the Mucin-Type N-Acetylgalactosamine-α-O-threonine into Protein in Escherichia coli | Xu R | 2004 Nov 11 |
|
15541297 | Specificity of Amaranthus leucocarpus syn. hypocondriacus lectin for O-glycopeptides | Hernández P | 2004 Nov 01 |
|
15780008 | Characterization of cultured insect cells selected by Bacillus thuringiensis crystal toxin | LIU K | 2004 Nov |
|
15522176 | [Correlation of MUC1 expression to adhesion of breast cancer cell line MDA-MB-231] | Lu L | 2004 Nov |
|
15539510 | Improved Affinity of a Human Anti-Entamoeba histolyticaGal/GalNAc Lectin Fab Fragment by a Single Amino Acid Modification of the Light Chain | Tachibana H | 2004 Nov |
|
15688937 | [Structural diversity of O-polysaccharides and serological classification of Pseudomonas syringae pv. garcae and other strains of genomospecies 4] | Ovod VV | 2004 Nov |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025